nVerses Capital, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 2011399 WELLINGTON, FL

Position in NBIX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$212,191

-$179,557 QoQ

Shares Held

1,259

-63.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#594

of 768 holders

Holding Since

Sep 2024

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

nVerses Capital, LLC holds $1,009,100 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (21.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	4,380	$349,217
2	HIMS	Hims & Hers Health, Inc.	7,093	$245,914
3	NBIX	Neurocrine Biosciences Inc This page	1,259	$212,191
4	COLL	Collegium Pharmaceutical, Inc	5,574	$201,778
5	ESPR	Esperion Therapeutics, Inc.	19,453	$0

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$212,191	1,259	-63.0%	Shares	Sole	2026-08-04
2024-09-30	$391,748	3,400	—	Shares	Sole	2024-10-16
No filing history on record for this holder in this stock.